CompaniesByCap
CRNX
Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ · Healthcare

Crinetics Pharmaceuticals Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue7.7M1.0M4.0M0071,0001.2M2.4M2.0M589,000
Gross Profit6.6M1.0M4.0M
Profitability
Operating Income-516.8M-338.9M-222.6M-167.9M-107.7M-75.0M-53.8M-28.7M-9.1M-6.0M
EBITDA-512.9M-336.1M-221.5M-166.9M-106.8M-74.0M-52.9M-28.2M-9.0M-6.0M
Net Income-465.3M-298.4M-214.5M-163.9M-107.6M-73.8M-50.4M-27.1M-9.2M-6.0M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)94M81M58M52M38M30M24M0M2M

Crinetics Pharmaceuticals Inc. Income Statement — FAQ

Crinetics Pharmaceuticals Inc. (CRNX) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRNX's income statement history?

The chart and table above show Crinetics Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.